Guangyan Mu

626 total citations
52 papers, 383 citations indexed

About

Guangyan Mu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Guangyan Mu has authored 52 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 13 papers in Internal Medicine. Recurrent topics in Guangyan Mu's work include Atrial Fibrillation Management and Outcomes (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Guangyan Mu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (14 papers) and Venous Thromboembolism Diagnosis and Management (13 papers). Guangyan Mu collaborates with scholars based in China, United States and United Kingdom. Guangyan Mu's co-authors include Yimin Cui, Qian Xiang, Qiufen Xie, Lingyue Ma, Shuang Zhou, Zhiyan Liu, Shuqing Chen, Kun Hu, Hanxu Zhang and Jie Jiang and has published in prestigious journals such as Frontiers in Immunology, European Respiratory Journal and Nutrients.

In The Last Decade

Guangyan Mu

48 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangyan Mu China 11 143 99 75 52 51 52 383
Xiling Jiang United States 10 114 0.8× 62 0.6× 98 1.3× 39 0.8× 24 0.5× 18 455
Mu-Peng Li China 11 112 0.8× 47 0.5× 92 1.2× 25 0.5× 22 0.4× 27 332
Janice Rischke Canada 11 149 1.0× 84 0.8× 48 0.6× 24 0.5× 104 2.0× 16 396
D. A. Zateyshchikov Russia 8 289 2.0× 133 1.3× 78 1.0× 22 0.4× 73 1.4× 72 428
Jean C. Grégoire Canada 8 211 1.5× 207 2.1× 121 1.6× 11 0.2× 29 0.6× 14 505
Kavita Shalia India 10 127 0.9× 74 0.7× 57 0.8× 32 0.6× 8 0.2× 32 334
Myra F. Barginear United States 13 69 0.5× 39 0.4× 132 1.8× 60 1.2× 94 1.8× 29 540
Sandro Parrotto Italy 6 67 0.5× 127 1.3× 92 1.2× 21 0.4× 11 0.2× 6 355
Hendrik J.T. Ruven Netherlands 9 211 1.5× 106 1.1× 154 2.1× 45 0.9× 47 0.9× 9 443

Countries citing papers authored by Guangyan Mu

Since Specialization
Citations

This map shows the geographic impact of Guangyan Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyan Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyan Mu more than expected).

Fields of papers citing papers by Guangyan Mu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyan Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyan Mu. The network helps show where Guangyan Mu may publish in the future.

Co-authorship network of co-authors of Guangyan Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyan Mu. A scholar is included among the top collaborators of Guangyan Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyan Mu. Guangyan Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yilin, Junwei Cui, Yuanyuan Li, et al.. (2025). Rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in adults: a prospective multicentre study. European Respiratory Journal. 65(1). 2401493–2401493. 1 indexed citations
3.
Wang, Zhe, et al.. (2024). C-type lectin-like receptor 2: roles and drug target. Thrombosis Journal. 22(1). 27–27. 5 indexed citations
4.
5.
Liu, Zhiyan, Guangyan Mu, Hanxu Zhang, et al.. (2023). Integrated Pharmacokinetics/Pharmacodynamics Model and Simulation of the Ticagrelor Effect on Patients with Acute Coronary Syndrome. Clinical Pharmacokinetics. 62(3). 435–447. 1 indexed citations
6.
Zhang, Hanxu, Shuang Zhou, Zhiyan Liu, et al.. (2022). Ferroptosis of Endothelial Cells in Vascular Diseases. Nutrients. 14(21). 4506–4506. 22 indexed citations
7.
Xie, Qiufen, Yuan Li, Zhiyan Liu, et al.. (2022). SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population. Frontiers in Genetics. 13. 873031–873031. 4 indexed citations
8.
Xiang, Qian, Zhiyan Liu, Guangyan Mu, et al.. (2022). Effect of Genetic Polymorphism Including NUP153 and SVEP1 on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Subjects. Clinical Drug Investigation. 42(5). 447–458. 1 indexed citations
9.
Zhang, Hanxu, Zhuo Zhang, Zhiyan Liu, et al.. (2022). Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic–pharmacodynamic profiles of rivaroxaban. Human Genomics. 16(1). 72–72. 6 indexed citations
10.
Liu, Zhiyan, Qiufen Xie, Hanxu Zhang, et al.. (2021). Target Drug-Calibrated Anti-Xa Activity Assays and Expected Peak–Trough Levels in an Asian Population: A Multicenter Study. American Journal of Cardiovascular Drugs. 21(6). 669–679. 7 indexed citations
11.
Mu, Guangyan, Jiayi Wang, Zhiyan Liu, et al.. (2021). Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis. BMC Cancer. 21(1). 960–960. 20 indexed citations
12.
Mu, Guangyan, Hanxu Zhang, Zhiyan Liu, et al.. (2021). Standard- vs. low-dose rivaroxaban in patients with atrial fibrillation: a systematic review and meta-analysis. European Journal of Clinical Pharmacology. 78(2). 181–190. 2 indexed citations
13.
Liu, Zhiyan, Hanxu Zhang, Qiufen Xie, et al.. (2020). Different Coagulation Indicators in Predicting Clinical Outcomes for Patients With Direct Oral Anticoagulants: A Systematic Review and Meta-analysis. Clinical Therapeutics. 42(10). 2066–2081.e9. 4 indexed citations
14.
Mu, Guangyan, Qian Xiang, Shuang Zhou, et al.. (2020). Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials. Advances in Therapy. 37(4). 1496–1521. 22 indexed citations
15.
16.
Xiang, Qian, Zhiyan Liu, Yanyan Yu, et al.. (2020). Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report. BMC Pharmacology and Toxicology. 21(1). 43–43. 2 indexed citations
17.
Chang, Guodong, Qiufen Xie, Lingyue Ma, et al.. (2019). Accuracy of HAS‐BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation: A network meta‐analysis. Journal of Thrombosis and Haemostasis. 18(4). 791–801. 40 indexed citations
18.
Xiang, Qian, Shuqing Chen, Lingyue Ma, et al.. (2018). Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis. The Pharmacogenomics Journal. 18(6). 721–729. 42 indexed citations
19.
Xiang, Qian, Xiaodan Zhang, Lingyue Ma, et al.. (2018). The association between the SLCO1B1, apolipoprotein E, and CYP2C9 genes and lipid response to fluvastatin. Pharmacogenetics and Genomics. 28(12). 261–267. 11 indexed citations
20.
Zhang, Zhuo, Qian Xiang, Guangyan Mu, et al.. (2018). XRCC1 polymorphism and overall survival in ovarian cancer patients treated with platinum-based chemotherapy. Medicine. 97(45). e12996–e12996. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiling Jiang Breakdown of academic impact, for papers by Mu-Peng Li Breakdown of academic impact, for papers by Janice Rischke Breakdown of academic impact, for papers by D. A. Zateyshchikov Breakdown of academic impact, for papers by Jean C. Grégoire Breakdown of academic impact, for papers by Kavita Shalia Breakdown of academic impact, for papers by Myra F. Barginear Breakdown of academic impact, for papers by Sandro Parrotto Breakdown of academic impact, for papers by Hendrik J.T. Ruven
Rankless by CCL
2026